Plain-English translation of NCT06878027 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →Researchers are investigating whether a new urine test can detect bladder cancer earlier and more accurately than current methods. The test looks for specific chemical markers in urine that may indicate cancer is present or could return. This study will compare the results between people with bladder cancer and healthy volunteers to see if the test works reliably in real-world settings.
Current bladder cancer screening methods can be invasive and uncomfortable. This trial aims to develop a simple, non-invasive urine test that could catch cancer at earlier stages when treatment is often more effective, and help predict whether patients are likely to have a recurrence.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be asked to provide a urine sample that researchers will analyze using advanced genetic testing techniques. If you are a patient with bladder cancer, your sample will be compared with samples from healthy volunteers to see if the test can reliably detect cancer markers. The study involves 100 total participants and does not require ongoing medication or invasive procedures beyond the urine collection.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Italy
Sponsor
Regina Elena Cancer Institute
Collaborators
Azienda Ospedaliera Santa Maria Degli Angeli, Istituto per lo Studio, la Prevenzione e la Rete Oncologica
Enrollment target
~100 participants
Started
August 2024
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Giuseppe Simone, Medical Doctor
Regina Elena Cancer Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.